Terapia con células madres mesenquimales: plasma rico en plaquetas en lesiones tendinosas y ligamentosas

Abstract

In the field of sports medicine, injuries can occur at different levels, most of them correspond to tendon injuries either in their extension or insertion point, becoming chronic in many cases. The clinical trials reviewed on the benefits of platelet-rich plasma therapy have awakened the interest of specialists for its application in the development of new therapies for chronic injuries that affect quality of life. General objective: to describe the benefits of mesenchymal stem cell therapy in tendon and ligament injuries. Observations: despite the fact that PRP has been under study for more than a decade, the peak of trials is just in 2019, being mostly compared with corticosteroids in short and/or long term based on pain and functionality scales either as monotherapy by infiltration or adjuvant to surgical treatment, with positive results in most cases, however, the need for a broader study and even more varied in terms of the type of injury to be treated is much repeated. Conclusions: PRP presents better results in combined therapy with SH, and as for monotherapy, based on the evidence, it is recommended to stop the infiltrative practice with corticosteroids due to its limited benefit in the short term, being widely surpassed in the long term by PRP. Ligaments present less benefit, only the catalytic effects of healing predominate.